Advertisement

Hepatocellular Carcinoma

Diagnosis and Treatment

  • Brian I. Carr

Part of the Current Clinical Oncology book series (CCO)

Table of contents

  1. Front Matter
    Pages i-xv
  2. Donna L. White, Amir Firozi, Hashem B. El-Serag
    Pages 1-25
  3. John D. Groopman, Kimberly Brodovicz, Thomas W. Kensler
    Pages 27-53
  4. Sheeno P. Thyparambil, Ricky D. Edmondson, Yvonne P. Dragan
    Pages 55-107
  5. Anuradha Budhu, Junfang Ji, Xin Wei Wang
    Pages 131-182
  6. Michael A. Nalesnik, Tong Wu, Eizaburo Sasatomi, Anthony J. Demetris
    Pages 183-233
  7. Hie-Won L. Hann, Mark Feitelson
    Pages 235-257
  8. Ryota Masuzaki MD, Haruhiko Yoshida MD, Naoya Kato MD, Masao Omata MD
    Pages 259-281
  9. David H. Van Thiel, Giuliano Ramadori
    Pages 283-307
  10. Michael P. Federle, Satoshi Goshima
    Pages 349-367
  11. Tae Kyoung Kim, Hyun-Jung Jang, Stephanie R Wilson
    Pages 387-406
  12. Tito Livraghi MD, Maria Franca Meloni MD, Anita Andreano MD
    Pages 407-420
  13. Kevin Tri Nguyen, David A. Geller
    Pages 421-451
  14. Ronnie Tung Ping Poon MS, PhD, FRCS (Edin), FACS
    Pages 453-465
  15. T. Clark Gamblin MD, MS, Sydney D. Finkelstein MD, J. Wallis Marsh MD
    Pages 467-490
  16. Hiroyuki Furukawa MD, Satoru Todo MD
    Pages 491-525
  17. Brian I. Carr, Srikanth Nagalla
    Pages 527-568
  18. Nikhil B. Amesur MD, Albert B. Zajko MD
    Pages 569-588
  19. Brian I. Carr MD, FRCP, PhD, Susan Kralian PhD
    Pages 589-614
  20. Andrew S. Kennedy
    Pages 615-640
  21. Jennifer L. Steel, Andrea DiMartini, Mary Amanda Dew
    Pages 641-711
  22. Brian I Carr, J. Wallis Marsh, David A. Geller
    Pages 713-720
  23. Back Matter
    Pages 1-28

About this book

Introduction

Hepatocellular cancer is the the fifth most common cancer, with 600,000 new cases reported each year worldwide. Additionally, exciting changes in the science of HCC in the last four years have turned the practice of diagnosing and treating the disease upside down. In Hepatocellular Carcinoma: Diagnosis and Treatment, Second Edition, the leading experts in the field of HCC thoroughly update and expand upon the critically acclaimed first edition with all the latest developments in the diagnosis and treatment of primary liver cancer. The book details for physicians the diagnostic and therapeutic decision making process for dealing with such problems as incidental tumors in the liver transplant, the role of neo-adjuvant chemotherapy, intra-arterial vs intravenous therapy, the uses of embolization, and the significance of portal vein thrombus. New chapters discuss the introduction into clinical practice of cell cycle growth inhibitors, an expanded knowledge of Genomics and Proteomics, and novel ways of delivering intra-hepatic chemotherapy. This cutting-edge text is a vital resource and must have for today’s hepatologists and medical and surgical oncologists.

Keywords

Carcinom Cell Cycle Growth Inhibitors HCC Tumor Classifications Intra-hepatic Chemotherapy Liver Transplants Primary Liver Cancer Tumor diagnosis imaging techniques ultrasound

Editors and affiliations

  • Brian I. Carr
    • 1
  1. 1.Kimmel Cancer CenterThomas Jefferson UniversityPhiladelphiaUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-60327-376-3
  • Copyright Information Humana Press, a part of Springer Science+Business Media, LLC 2010
  • Publisher Name Humana Press
  • eBook Packages Medicine
  • Print ISBN 978-1-60327-373-2
  • Online ISBN 978-1-60327-376-3
  • Buy this book on publisher's site